Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 11,159,768,000
  • Shares Outstanding, K 65,100
  • 60-Month Beta 0.94
Trade IBB with:
  • Price/Earnings ttm 35.35
  • Annual Dividend & Yield 0.28 (0.16%)
  • Most Recent Dividend 0.023 on 06/10/21
  • Management Fee 0.46%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 21.52%
  • Historical Volatility 13.61%
  • IV Percentile 23%
  • IV Rank 22.30%
  • IV High 36.01% on 10/28/20
  • IV Low 17.36% on 06/25/21
  • Put/Call Vol Ratio 1.53
  • Today's Volume 2,620
  • Volume Avg (30-Day) 3,552
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 32,487
  • Open Int (30-Day) 41,239

Price Performance

See More
Period Period Low Period High Performance
1-Month
168.36 +1.92%
on 09/20/21
176.02 -2.51%
on 09/02/21
+4.44 (+2.66%)
since 08/20/21
3-Month
157.11 +9.22%
on 07/15/21
177.37 -3.25%
on 08/10/21
+10.69 (+6.64%)
since 06/22/21
52-Week
128.23 +33.82%
on 11/02/20
177.37 -3.25%
on 08/10/21
+37.76 (+28.21%)
since 09/22/20

Most Recent Stories

More News
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 76.90 (-0.44%)
BIIB : 289.32 (-2.10%)
ILMN : 434.59 (-0.04%)
IBB : 171.60 (+0.02%)
CTLT : 137.21 (+0.82%)
XBI : 130.62 (+0.28%)
Moderna ETFs to Rally on Two-in-One Vaccine Booster Shot News

Moderna is expected to gain on approval for booster shots and new positive data on its COVID-19 vaccine.

MRNA : 440.72 (+1.54%)
IBB : 171.60 (+0.02%)
BBH : 215.91 (+0.02%)
IDNA : 54.50 (-0.06%)
GERM : 43.38 (-0.14%)
Analysts Make the Case for Small-Cap Biotech Stocks This Fall (INMB, DVAX, SAVA, ICPT, IMGN, ATRX)

IBB : 171.60 (+0.02%)
MRNA : 440.72 (+1.54%)
INMB : 19.21 (+3.22%)
ATRX : 0.1530 (-11.05%)
SAVA : 52.31 (-1.04%)
DVAX : 18.79 (+26.45%)
ICPT : 15.67 (+3.77%)
IMGN : 5.97 (+0.67%)
Best ETF Areas for Placing Your Bets in September

Let's take a look at some ETF areas that can be good investment options for September.

IBB : 171.60 (+0.02%)
XLK : 154.53 (+1.37%)
XBI : 130.62 (+0.28%)
BBH : 215.91 (+0.02%)
IYW : 105.47 (+1.10%)
VGT : 417.13 (+1.48%)
IVE : 146.97 (+1.10%)
MGV : 98.96 (+0.70%)
WFH : 76.43 (+1.22%)
EDUT : 11.37 (+0.11%)
EDOC : 18.70 (+0.16%)
Pfizer Vaccine Approval Triggers a Surge in Biotech ETFs

The biotech space has once again come under the spotlight as the FDA has granted the first full U.S. approval to Pfizer (PFE)/BioNTech's (BNTX) coronavirus vaccine.

PFE : 43.95 (+0.07%)
IBB : 171.60 (+0.02%)
XBI : 130.62 (+0.28%)
BBH : 215.91 (+0.02%)
FBT : 172.56 (-0.46%)
BTEC : 56.91 (+0.29%)
BNTX : 339.26 (-0.61%)
Biotech ETFs to Benefit From Latest Booster Update

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

PFE : 43.95 (+0.07%)
MRNA : 440.72 (+1.54%)
IBB : 171.60 (+0.02%)
XBI : 130.62 (+0.28%)
BBH : 215.91 (+0.02%)
FBT : 172.56 (-0.46%)
BTEC : 56.91 (+0.29%)
BNTX : 339.26 (-0.61%)
Moderna ETFs to Shine Bright on Booster Update, New Study Data

Moderna is expected to gain on approval for booster shots and new positive data on its COVID-19 vaccine.

PFE : 43.95 (+0.07%)
MRNA : 440.72 (+1.54%)
IBB : 171.60 (+0.02%)
BBH : 215.91 (+0.02%)
IDNA : 54.50 (-0.06%)
GERM : 43.38 (-0.14%)
How Are Biotech ETFs Reacting to These Q2 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

BIIB : 289.32 (-2.10%)
AMGN : 213.64 (-0.80%)
GILD : 71.38 (-0.49%)
IBB : 171.60 (+0.02%)
XBI : 130.62 (+0.28%)
BBH : 215.91 (+0.02%)
ETF Investing Areas to Consider for August

Let's take a look at some ETF areas that can be good investment options for August.

IBB : 171.60 (+0.02%)
XLK : 154.53 (+1.37%)
SDY : 117.92 (+0.68%)
VIG : 156.48 (+0.68%)
NOBL : 89.99 (+0.27%)
XBI : 130.62 (+0.28%)
DVY : 115.18 (+1.17%)
BBH : 215.91 (+0.02%)
IYW : 105.47 (+1.10%)
VGT : 417.13 (+1.48%)
QTEC : 165.10 (+1.22%)
WFH : 76.43 (+1.22%)
EDUT : 11.37 (+0.11%)
EDOC : 18.70 (+0.16%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 76.90 (-0.44%)
BIIB : 289.32 (-2.10%)
ILMN : 434.59 (-0.04%)
IBB : 171.60 (+0.02%)
CTLT : 137.21 (+0.82%)
XBI : 130.62 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

3rd Resistance Point 175.24
2nd Resistance Point 173.94
1st Resistance Point 172.77
Last Price 171.60
1st Support Level 170.30
2nd Support Level 169.00
3rd Support Level 167.83

See More

52-Week High 177.37
Last Price 171.60
Fibonacci 61.8% 158.60
Fibonacci 50% 152.80
Fibonacci 38.2% 147.00
52-Week Low 128.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar